2型糖尿病患者目标范围内时间与全因及心血管死亡风险的前瞻性队列研究
该研究纳入上海单中心6225例成人2型糖尿病患者,基线用连续血糖监测测定目标范围内时间(TIR),随访中位6.9年。结果显示TIR越低,全因死亡和心血管死亡风险越高,呈显著剂量反应关系,支持TIR作为长期不良临床结局的替代指标。
要点
- TIR≤50%者全因死亡风险较TIR>85%者增加83%(HR 1.83,95%CI 1.48-2.28)。
- TIR 51-70%者全因死亡风险亦显著升高(HR 1.30,95%CI 1.04-1.63)。
- TIR与全因及心血管死亡风险均呈显著趋势关联(P趋势分别<0.001和0.015)。
核心结论
- 在2型糖尿病患者中,较低TIR与全因死亡和心血管死亡风险升高相关,支持TIR作为长期不良临床结局的替代标志物。
主要发现
- 中位随访6.9年期间共838例死亡,其中287例死于心血管疾病。
- 以TIR>85%为参照,TIR 71-85%、51-70%和≤50%的全因死亡多因素校正HR分别为1.23(95%CI 0.98-1.55)、1.30(95%CI 1.04-1.63)和1.83(95%CI 1.48-2.28),P趋势<0.001。
- 以TIR>85%为参照,TIR 71-85%、51-70%和≤50%的心血管死亡多因素校正HR分别为1.35(95%CI 0.90-2.04)、1.47(95%CI 0.99-2.19)和1.85(95%CI 1.25-2.72),P趋势=0.015。
临床怎么用
- 临床可将TIR作为评估2型糖尿病患者长期死亡风险的血糖控制指标,TIR≤50%提示全因和心血管死亡风险显著升高。
局限性
- 研究为单中心队列,TIR仅基于基线一次连续血糖监测测定,未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: There is growing evidence linking time in range (TIR), an emerging metric for assessing glycemic control, to diabetes-related outcomes. We aimed to investigate the association between TIR and mortality in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: A total of 6,225 adult patients with type 2 diabetes were included from January 2005 to December 2015 from a single center in Shanghai, China. TIR was measured with continuous glucose monitoring at baseline, and the participants were stratified into four groups by TIR: >85%, 71-85%, 51-70%, and ≤50%. Cox proportional hazards regression models were used to estimate the association between different levels of TIR and the risks of all-cause and cardiovascular disease (CVD) mortality. RESULTS: The mean age of the participants was 61.7 years at baseline. During a median follow-up of 6.9 years, 838 deaths were identified, 287 of which were due to CVD. The multivariable-adjusted hazard ratios associated with different levels of TIR (>85% [reference group], 71-85%, 51-70%, and ≤50%) were 1.00, 1.23 (95% CI 0.98-1.55), 1.30 (95% CI 1.04-1.63), and 1.83 (95% CI 1.48-2.28) for all-cause mortality (P for trend <0.001) and 1.00, 1.35 (95% CI 0.90-2.04), 1.47 (95% CI 0.99-2.19), and 1.85 (95% CI 1.25-2.72) for CVD mortality (P for trend = 0.015), respectively. CONCLUSIONS: The current study indicated an association of lower TIR with an increased risk of all-cause and CVD mortality among patients with type 2 diabetes, supporting the validity of TIR as a surrogate marker of long-term adverse clinical outcomes.
引用
- Lu J, Wang C, Shen Y, et al. Time in Range in Relation to All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes: A Prospective Cohort Study. Diabetes Care. 2020. PMID: 33097560. doi:10.2337/dc20-1862
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。